Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis

Leukemia Research

Volumn 32, Issue 4, 2008, Pages 593-597

  Martinelli, Silvia ^a   Maffei, Rossana ^a   Castelli, Ilaria ^a   Santachiara, Rita ^a   Zucchini, Patrizia ^a   Fontana, Marcella ^a   Bonacorsi, Goretta ^a   Leonardi, Giovanna ^a   Marasca, Roberto ^a   Torelli, Giuseppe ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Angiogenesis; Angiopoietin 2; CD38; CLL; Disease progression; IgVH mutational status

Indexed keywords

ANGIOPOIETIN 2; CD38 ANTIGEN; IMMUNOGLOBULIN; RNA;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CANCER GROWTH; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-2; ANTIGENS, CD38; BONE MARROW; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, B-CELL; MALE; MICROCIRCULATION; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 39049120668     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.09.002     Document Type: Article

References (8)

1. Peterson L., and Kini A.R. Angiogenesis is increased in B-cell chronic lymphocytic leukemia. Blood 97 (2001) 2529
2. Kini A.R., Kay N.E., and Peterson L.C. Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Leukemia 14 (2000) 1414-1418
3. Chen H., Treweeke A.T., West D.C., Till K.J., Cawley J.C., Zuzel M., et al. In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells. Blood 96 (2000) 3181-3187
4. Molica S., Vacca A., Ribatti D., Cuneo A., Cavazzini F., Levato D., et al. Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. Blood 100 (2002) 3344-3351
5. Molica S., Cutrona G., Vitelli G., Mirabelli R., Molica M., Digiesi G., et al. Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukaemia. Leuk Res May (2007) [Epub ahead of print]
6. Huttmann A., Klein-Hitpass L., Thomale J., Deenen R., Carpinteiro A., Nuckel H., et al. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status. Leukemia 20 (2006) 1774-1782
7. Maffei R., Marasca R., Martinelli S., Castelli I., Santachiara R., Morandi E., et al. Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status. Leukemia 21 (2007) 1312-1315
8. Shanafelt D., Geyer S., Bone N., Schwager S., Lee Y.K., Nowakowski G., et al. Evaluation of the prognostic implications of pro- and anti-angiogenic cytokines in 311 patients with untreated chronic lymphocytic leukemia. Blood 106 11 (2005) [abstract 712]